Abstract
The incidence of atherosclerosis increases with age. Oxidative changes in proteins and lipids are considered to be among the molecular mechanisms leading to endothelial dysfunction. Paraoxonase (PON1) is exclusively associated with high-density lipoprotein (HDL) and protects both HDL and low-density lipoprotein (LDL) from oxidation. PON1 has two cysteine residues for its antioxidant function. We investigated the relation between PON1 activity and protein oxidation parameters such as protein hydroperoxides (P-OOH), protein carbonyl (PCO), total thiol (T-SH) and advanced oxidation protein products (AOPP). Our study also covered other oxidative stress parameters such as oxidised LDL (oxLDL) and superoxide dismutase activity in the plasma of young, middle-aged and elderly individuals. PON1 activity of elderly and middle-aged individuals was decreased significantly compared with that in the young group. oxLDL levels of elderly individuals were increased significantly compared with those of both the young and middle-aged individuals. P-OOH, PCO and AOPP levels of the elderly and middle aged individuals were higher compared with those of the young. On the other hand, T-SH levels of the elderly and middle-aged individuals were lower compared with those of the young. Side by side with the decrease in the T-SH levels in the middle-aged and elderly groups as compared to the young, the increase we have observed in other protein oxidation parameters in the groups leading to decreasing PON1 activity might, we think, create a predisposition to atherosclerosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Seres I, Paragh G, Deschene E et al (2004) Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 39:59–66
Lusis AJ (2000) Atherosclerosis. Nature 407:233–241
Reaven PD, Napoli C, Merat S, Witztumc JI (2000) Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 34:527–537
Bonnefont-Rousselot D, Therond P, Beaudeux JL et al (1999) High density lipoproteins (HDL) and oxidative hypothesis of atherosclerosis. Clin Chem Lab Med 37:938–948
Costa LG, Vitalone A, Cole TB, Furlong CE (2005) Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69:541–550
Watson AD, Berliner JA, Hama SY et al (1995) Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882–2891
Gugliucci A, Lunceford N, Kinugasa E et al (2007) Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clin Chim Acta 384:105–112
Jaouad L, Guise C, Berrougui H et al (2006) Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1’s free sulfhydryl groups. Atherosclerosis 185:191–200
Woods AA, Linton SM, Davies MJ (2003) Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J 370:729–735
Kaneda H, Taguchi J, Ogasawara K et al (2002) Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 162:221–225
Şkvařilová M, Bulava A, Stejskal D et al (2005) Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Papers 149:83–87
Stadtman ER (2004) Role of oxidant species in aging. Curr Med Chem 11:1105–1112
Çakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–557
Kalousová M, Zima T, Tesár V et al (2005) Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. Mutat Res 579:37–46
Capéillere-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V (2004) Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta 1689:91–102
— (2002) World Medical Association Declaration Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med 48:206–208
Bridges AB, Fisher TC, Scot N et al (1992) Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Radic Res 16:89–97
Hasselwander O, Savage DA, McMaster D et al (1999) Paraoxonase polymorphism are not associated with cardiovascular risk in renal transplants recipients. Kidney Int 56:289–298
Saha N, Roy AC, Teo SH et al (1991) Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 40:277–282
Paragh G, Asztalos L, Seres I et al (1999) Serum paraoxonase activity changes in uremic and kidney transplanted patients. Nephron 83:126–131
Eckerson HW, Romson J, Wyte C, La Du BN (1983) The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 35:214–227
Gay CA, Gebicki JM (2003) Measurement of protein and lipid hydroperoxides in biological systems by the ferric-xylenol orange method. Anal Biochem 315:29–35
Zbikowska HM, Nowak P, Wachowicz B (2006) Protein modification caused by a high dose of gamma irradiation in cryo-sterilized plasma: Protective effects of ascorbate. Free Radic Biol Med 40:536–542
Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363
Hu ML (1994) Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 233:381–385
Witko-Sarsat V, Friedlander M, Capéillere-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313
Çakatay U, Kayali R (2005) Plasma protein oxidation in aging rats after alpha-lipoic acid administration. Biogerontology 6:87–93
Young IS, Woodside JV (2001) Antioxidants in health and disease. J Clin Pathol 54:176–186
Alderman C, Shah S, Foreman JC et al (2002) The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med 32:377–385
Gieseg S, Duggan S, Gebicki JM (2000) Peroxidation of proteins before lipids in U937 cells exposed to peroxyl radicals. Biochem J 350:215–218
Gebicki S, Gebicki JM (1999) Cross-linking of DNA and proteins induced by protein hydroperoxides. Biochem J 338:629–636
Davies MJ, Fu S, Dean RT (1995) Protein hydroperoxides can give rise to reactive free radicals. Biochem J 305:643–649
Soszynski M, Filipiak A, Bartosz G, Gebicki JM (1996) Effect of amino acid peroxides on the erythrocyte. Free Radic Biol Med 20:45–51
Eaton P (2006) Protein thiol oxidation in health and disease. Techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic Biol Med 40:1889–1899
Morgan PE, Dean RT, Davies MJ (2005) Inhibition of glyceraldehyde-3-phosphate dehydrogenase by peptide and protein peroxides generated by singlet oxygen attack. Eur J Biochem 269:1916–1925
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Çakatay, U., Kayali, R. & Uzun, H. Relation of plasma protein oxidation parameters and paraoxonase activity in the ageing population. Clin. Exper.Med. 8, 51–57 (2008). https://doi.org/10.1007/s10238-008-0156-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10238-008-0156-0